ADRENOCORTICAL CARCINOMA WITH FEMINIZATION AND HYPERTENSION ASSOCIATED WITH A DEFECT IN 11-BETA-HYDROXYLATION.
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000152:Acne Vulgaris; D000305:Adrenal Cortex Hormones; D000310:Adrenal Gland Neoplasms; D018268:Adrenocortical Carcinoma; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000728:Androgens; D000738:Androsterone; D000970:Antineoplastic Agents; D004232:Diuretics; D004487:Edema; D004967:Estrogens; D005043:Etiocholanolone; D005262:Feminization; D006801:Humans; D006900:Hydroxylation; D006973:Hypertension; D008297:Male; D008797:Metyrapone; D009369:Neoplasms / Q000175:diagnosis*; D010600:Pharmacology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000728:Androgens; D000970:Antineoplastic Agents; D004232:Diuretics; D004967:Estrogens; D000324:Adrenocorticotropic Hormone; D005043:Etiocholanolone; D000738:Androsterone; D008797:Metyrapone
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ACNE; ADRENAL CORTEX HORMONES; ADRENAL GLAND NEOPLASMS; ANDROGENS; ANDROSTERONE; ANTINEOPLASTIC AGENTS; CORTICOTROPIN, THERAPEUTIC; DIURETICS; EDEMA; ESTROGENS; ETIOCHOLANOLONE; HYPERTENSION; METYRAPONE; NEOPLASM DIAGNOSIS; PHARMACOLOGY